Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00957853
Title Preoperative Treatment With Cetuximab and/or IMC-A12
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab

Cixutumumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.